Boston Scientific appoints David Habiger to Board of Directors

BOSTON SCIENTIFIC CORP

Board expanded from 10 to 11 members; Habiger effective July 30, 2024.
Will serve on Audit Committee and Executive Compensation and Human Resources Committee.
Receives pro-rated cash retainer of ~$94,175 and equity award valued at ~$161,981.
Habiger is president and CEO of J.D. Power; previously led multiple tech firms.
Appointment until 2025 annual meeting; indemnification agreement to be entered.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

David C. Habiger

Director

BSX · BOSTON SCIENTIFIC CORP

Effective: 2024-07-30
Filed: July 30, 2024, 7:59 PM ET

appointed David C. Habiger, to be a director of the Company, to hold office until the next annual meeting of stockholders, effective July 30, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David C. Habiger was appointed as Director at BOSTON SCIENTIFIC CORP.

Action: appointed
Role: Director

Exact text from the filing

appointed David C. Habiger, to be a director of the Company, to hold office until the next annual meeting of stockholders, effective July 30, 2024.

View on SEC.gov

BOSTON SCIENTIFIC CORP filing history →

Source: SEC EDGAR

accession 0000885725-24-000063

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.